Landscapes / Targets

KRAS G12D

22 drugs act on KRAS G12D, in 58 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs22

DrugHow it worksCompanyStageNext dateDetails
—
Hengrui · Public 600276.SS
Phase 3 Mar 2027Phase 1/2 trial completes
KRAS G12D inhibitor
GenFleet Therapeutics +1
Phase 3 30 Apr 2027Phase 2 trial completes
KRAS G12D inhibitor
Phase 3 Jun 2027Phase 1/2 trial completes
—
Phase 3 15 Sep 2028Phase 3 trial completes
KRAS G12D degrader
Phase 3 31 Aug 2029Phase 3 trial completes
—
Phase 2 30 Nov 2026soonPhase 2 trial completes
—
Phase 1/2 30 Oct 2027Phase 1/2 trial completes
—
Phase 1/2 —
—
Phase 1/2 —
—
Phase 1 15 Dec 2026soonPhase 1 trial completes
—
Phase 1 27 Mar 2027Phase 1 trial completes
—
Phase 1 1 Apr 2027Phase 1 trial completes
—
Phase 1 1 Jul 2027Phase 1 trial completes
—
AstraZeneca · Public AZN
Phase 1 30 Aug 2027Phase 1 trial completes
—
AstraZeneca · Public AZN
Phase 1 30 Aug 2027Phase 1 trial completes
—
Phase 1 11 Jan 2028Phase 1 trial completes
—
Eli Lilly · Public LLY
Phase 1 Mar 2028Phase 1 trial completes
—
Roche · Public ROG.SW
Phase 1 31 May 2028Phase 1 trial completes
—
Hengrui · Public 600276.SS
Phase 1 May 2028Phase 1 trial completes
—
Phase 1 30 Apr 2029Phase 1 trial completes

See all 22 drugs

Sign in free to see the whole list. No card, no password.

Sign in free

About this list

Checked
22 of 22 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow KRAS G12D

Following is part of Solo: you see every change to KRAS G12D the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in